BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22425739)

  • 21. Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
    Holzelova E; Vonarbourg C; Stolzenberg MC; Arkwright PD; Selz F; Prieur AM; Blanche S; Bartunkova J; Vilmer E; Fischer A; Le Deist F; Rieux-Laucat F
    N Engl J Med; 2004 Sep; 351(14):1409-18. PubMed ID: 15459302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of SLAM-associated protein in the pathogenesis of autoimmune diseases and immunological disorders.
    Furukawa H; Tohma S; Kitazawa H; Komori H; Nose M; Ono M
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):37-44. PubMed ID: 20049647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of common variable immunodeficiency patients and healthy individuals using autoimmune lymphoproliferative syndrome biomarkers.
    Roberts CA; Ayers L; Bateman EA; Sadler R; Magerus-Chatinet A; Rieux-Laucat F; Misbah SA; Ferry BL
    Hum Immunol; 2013 Dec; 74(12):1531-5. PubMed ID: 23993982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic defects of novo FAS and homozygous UNC13D leading to autoimmune lymphoproliferative syndrome-like disease: A 10-year-old Chinese boy case report.
    Gu H; Ma J; Chen Z; Wang J; Zhang R; Wu R
    Gene; 2018 Sep; 672():45-49. PubMed ID: 29864493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia).
    Vacek MM; Schäffer AA; Davis J; Fischer RE; Dale JK; Adams S; Straus SE; Puck JM
    Clin Immunol; 2006 Jan; 118(1):59-65. PubMed ID: 16257267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome.
    Rieux-Laucat F
    Curr Dir Autoimmun; 2006; 9():18-36. PubMed ID: 16394653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased proliferation of CD8+ T cells in SAP-deficient mice is associated with impaired activation-induced cell death.
    Chen G; Tai AK; Lin M; Chang F; Terhorst C; Huber BT
    Eur J Immunol; 2007 Mar; 37(3):663-74. PubMed ID: 17266174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and gene research of X-linked lymphoproliferative disease in a Chinese family].
    Zhu DX; Du J; Lan HK; Yu L; Feng ZC
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):244-8. PubMed ID: 17425868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FAS Haploinsufficiency Caused by Extracellular Missense Mutations Underlying Autoimmune Lymphoproliferative Syndrome.
    de Bielke MG; Perez L; Yancoski J; Oliveira JB; Danielian S
    J Clin Immunol; 2015 Nov; 35(8):769-76. PubMed ID: 26563159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accessory spleen: differential diagnosis for lymphoma in autoimmune lymphoproliferative syndrome.
    Georgin-Lavialle S; Aouba A; Canioni D; Rieux-Laucat F; Fischer A; Hermine O
    Pediatr Blood Cancer; 2010 Jul; 54(7):1020-2. PubMed ID: 20162683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.
    López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM
    Front Immunol; 2021; 12():671755. PubMed ID: 34447369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines.
    Nagy N; Cerboni C; Mattsson K; Maeda A; Gogolák P; Sümegi J; Lányi A; Székely L; Carbone E; Klein G; Klein E
    Int J Cancer; 2000 Nov; 88(3):439-47. PubMed ID: 11054674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FcRγ promotes T cell apoptosis in Fas-deficient mice.
    Juvet SC; Thomson CW; Kim EY; Joe B; Adeyi O; Zhang L
    J Autoimmun; 2013 May; 42():80-93. PubMed ID: 23313147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SH2D1A regulates T-dependent humoral autoimmunity.
    Hron JD; Caplan L; Gerth AJ; Schwartzberg PL; Peng SL
    J Exp Med; 2004 Jul; 200(2):261-6. PubMed ID: 15263031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer T cells and X-linked lymphoproliferative syndrome.
    Latour S
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):510-4. PubMed ID: 17989527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-linked lymphoproliferative syndromes and related autosomal recessive disorders.
    Veillette A; Pérez-Quintero LA; Latour S
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):614-22. PubMed ID: 24113228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Zhizhuo H; Junmei X; Yuelin S; Qiang Q; Chunyan L; Zhengde X; Kunling S
    Pediatr Blood Cancer; 2012 Mar; 58(3):410-4. PubMed ID: 21674762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal onset de novo SH2D1A mutation and lymphocytic choriomeningitis virus infection in a patient with X‑linked lymphoproliferative disease type 1: a case report.
    Liu J; Tian W; Wang F; Teng W; Zhang Y; Tong C; Zhang C; Ju Y; Zhang B; Zhao S; Liu H
    Mol Med Rep; 2015 May; 11(5):3291-4. PubMed ID: 25572984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin lesions in a boy with X-linked lymphoproliferative disorder: comparison of 5 SH2D1A deletion cases.
    Mejstríková E; Janda A; Hrusák O; Bucková H; Vlcková M; Hancárová M; Freiberger T; Ravcuková B; Vesely K; Fajkusová L; Kopecková L; Sumerauer D; Kabícková E; Sedivá A; Stary J; Sedlácek Z
    Pediatrics; 2012 Feb; 129(2):e523-8. PubMed ID: 22271700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A missense mutation in the extracellular domain of Fas: the most common change in Argentinean patients with autoimmune lymphoproliferative syndrome represents a founder effect.
    Simesen de Bielke MG; Yancoski J; Rocco C; Pérez LE; Cantisano C; Pérez N; Oleastro M; Danielian S
    J Clin Immunol; 2012 Dec; 32(6):1197-203. PubMed ID: 22752343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.